Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort studyXiaobin Zhang, Yin‐Kai Chao, Ming-Mo Hou et al.|BMC Cancer|2020Cited by 40
Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trialBerend J. van der Wilk, J.J.B. van Lanschot, Ben M. Eyck et al.|British journal of surgery|2020Cited by 20
Prolonged Time to Surgery in Patients With Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerHidde Overtoom, J.J.B. van Lanschot, Sjoerd M. Lagarde et al.|Annals of Surgery|2024Cited by 8